The Yale School of Public Health’s regulatory sciences program expansion builds on the current regulatory affairs track program, which focuses on the administrative, policy, and legal aspects of product regulation.
Tevogen Bio announced in a July 14, 2021 press release its support of the Yale School of Public Health’s regulatory sciences program expansion, providing students with professional training. This expanded program builds on the current regulatory affairs track in the Yale School of Public Health’s Master of Public Health program, which focuses on the administrative, policy, and legal aspects of product regulation.
Regulatory sciences on the other hand, focuses on the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of products made by pharmaceutical, biologic, and medical device organizations, in addition to other industries.
“Stakeholders are searching for talented and emerging leaders in regulatory science, but current educational programs are scarce,” said Sten H. Vermund, Dean of the Yale School of Public Health, in a press release. “With Tevogen Bio’s support, we have an opportunity to reimagine our program and to grow it into one that matriculates students who ultimately become national and international leaders in the field.”
Source: BusinessWire, Tevogen
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.